Chinese herbal medicine combined with cognitive-behavioural therapy for avoidant paruresis: a controlled trial

被引:0
作者
Liang, Shijie [1 ]
Zhou, Ying [2 ]
Yu, Chao [1 ,3 ]
Gao, Xiang [3 ,4 ]
Ji, Fangbin [4 ]
Fang, Qianyuan [1 ]
Zhang, Zhihang [1 ]
Yang, Libin [1 ]
Zhao, Youkang [1 ]
Zhao, Yuhui [1 ]
Yin, Renwu [1 ]
Chen, Kaimin [1 ]
Lu, Zheng [5 ,6 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Urol, Shanghai, Peoples R China
[2] Mental Hlth Ctr Huangpu, Psychol, Shanghai, Peoples R China
[3] Inst Huada Appl Psychol, Med Counseling Dept, Shanghai, Peoples R China
[4] Lehu Psychol Consulting Co LTD, Psychol Counseling Dept, Shanghai, Peoples R China
[5] Tongji Univ, Sch Med, Dept Psychiat, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China
关键词
cognitive behavioral therapy;
D O I
10.1136/gpsych-2023-101014
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Avoidant paruresis is a common clinical condition in urology and psychosomatic medicine. However, it has limited treatment options that are safe and effective with few side effects.Aims Our study aimed to investigate the effectiveness and safety of the Chinese herbal Yangxin Tongquan decoction combined with cognitive-behavioural therapy (CBT) for avoidant paruresis.Methods Sixty-eight patients with avoidant paruresis were divided into a treatment group (33 patients) and a control group (35 patients). The control group was assigned 10 weeks of CBT and systematic desensitisation. In addition to CBT and systematic desensitisation, the treatment group was given the Chinese herbal Yangxin Tongquan decoction during the 10-week study. The Shy Bladder Syndrome Scale (SBS) and the Self-rating Anxiety Scale (SAS) were administered before and after treatment to measure any change.Results The overall efficacy in the treatment group (n=30) was 80.0% vs 62.5% in the control group (n=33). Comparing pretreatment and post-treatment measures, both groups showed improvement in SBS scores and SAS scores (treatment group: t((SBS)) =8.397, p((SBS)) <0.001, t((SAS)) =8.216, p((SAS))<0.001; control group: t((SBS)) =6.802, p((SBS)) <0.001, t((SAS))=5.171, p((SAS)) <0.001). Moreover, both groups' SBS and SAS scores changed significantly over time (SBS scores: F-time =118.299, p<0.001; SAS scores: F-time =92.114, p<0.001). However, the treatment group performed better than the control group (SBS scores: F-time*group =5.709, p=0.020; SAS scores: F-time*group =7.235, p=0.009).Conclusions The Chinese herbal Yangxin Tongquan decoction combined with cognitive-behavioural psychotherapy positively affects the treatment of avoidant paruresis without significant adverse effects.
引用
收藏
页数:8
相关论文
共 50 条
[21]   Schematic model of cognitive-behavioural therapy during crisis associated with catastrophes Case Study: Earthquake of Pedernales, Ecuador 2016 [J].
Jaramillo, Marco ;
Ortiz, Diego ;
Ojeda, David .
2017 IEEE MEXICAN HUMANITARIAN TECHNOLOGY CONFERENCE (MHTC), 2017, :153-157
[22]   Controlled clinical trial of teacher-delivered Cognitive Behavioural Therapy (CBT) for adolescents with clinically diagnosed depressive disorder in Nigeria [J].
Are, Amos ;
Olisah, Victor ;
Bella-Awusah, Tolulope ;
Ani, Cornelius .
INTERNATIONAL JOURNAL OF MENTAL HEALTH, 2022, 51 (01) :4-23
[23]   Cognitive behavioral therapy for perinatal anxiety: A randomized controlled trial [J].
Green, Sheryl M. ;
Donegan, Eleanor ;
McCabe, Randi E. ;
Streiner, David L. ;
Agako, Arela ;
Frey, Benicio N. .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2020, 54 (04) :423-432
[24]   Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide: study protocol for a randomized controlled trial in veterans [J].
Melanie L. Bozzay ;
Jennifer M. Primack ;
Hannah R. Swearingen ;
Jennifer Barredo ;
Noah S. Philip .
Trials, 21
[25]   Combined transcranial magnetic stimulation and brief cognitive behavioral therapy for suicide: study protocol for a randomized controlled trial in veterans [J].
Bozzay, Melanie L. ;
Primack, Jennifer M. ;
Swearingen, Hannah R. ;
Barredo, Jennifer ;
Philip, Noah S. .
TRIALS, 2020, 21 (01)
[26]   The effects of digital cognitive behavioral therapy for insomnia on cognitive function: a randomized controlled trial [J].
Kyle, Simon D. ;
Hurry, Madeleine E. D. ;
Emsley, Richard ;
Marsden, Antonia ;
Omlin, Ximena ;
Juss, Amender ;
Spiegelhalder, Kai ;
Bisdounis, Lampros ;
Luik, Annemarie, I ;
Espie, Colin A. ;
Sexton, Claire E. .
SLEEP, 2020, 43 (09) :1-12
[27]   Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency [J].
Mari Campbell ;
Alex Clarke ;
Andrew Symes ;
Sarita Workman ;
Hans Stauss ;
A. David Webster .
Journal of Clinical Immunology, 2018, 38 :214-220
[28]   Acceptance and Commitment Therapy Versus Cognitive Behavioral Therapy for Insomnia: A Randomized Controlled Trial [J].
El Rafihi-Ferreira, Renatha ;
Hasan, Rosa ;
Toscanini, Andrea C. ;
Linares, Ila M. P. ;
Suzuki Borges, Daniel ;
Brasil, Israel P. ;
Carmo, Marwin ;
Lotufo Neto, Francisco ;
Morin, Charles .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2024, 92 (06) :330-343
[29]   Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency [J].
Campbell, Mari ;
Clarke, Alex ;
Symes, Andrew ;
Workman, Sarita ;
Stauss, Hans ;
Webster, A. David .
JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (02) :214-220
[30]   Cognitive behavioral therapy for the treatment of fibromyalgia syndrome: A randomized controlled trial [J].
Falcao, Dircilene M. ;
Sales, Luciane ;
Leite, Jose R. ;
Feldman, Daniel ;
Valim, Valeria ;
Natour, Jamil .
JOURNAL OF MUSCULOSKELETAL PAIN, 2008, 16 (03) :133-140